Valiant Laboratories Ltd

Integrated Filing — Corporate Governance (NSE XBRL)

Company Home Dashboard NSE Viewer

Filing Summary

Company
Valiant Laboratories Limited
Symbol
VALIANTLAB
Quarter Ended
31-Mar-2026
Submission
New

General Disclosures

Advertisements As Per Regulation471
Yes
Annual Return As Provided Under Section92Of The Companies Act2013
Yes
Approval For Material Related Party Transactions
Yes
Approval Of The Board And Shareholders For Compensation Or Profit Sharing
Not Applicable
Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls
Not Applicable
Board Composition
Yes
Code Of Conduct
Yes
Compliance Certificate
Yes
Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation
Yes
Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46
Yes
Credit Rating Or Revision In Credit Rating Obtained
Yes
Date Of End Of Financial Year
31-Mar-2026
Date Of End Of Reporting Period
31-Mar-2026
Date Of Signing
24-Apr-2026
Date Of Start Of Financial Year
01-Apr-2025
Designation Of Person
Company Secretary and Compliance Officer
Designation Of Person Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Annual Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Quartely Affirmations
Company Secretary and Compliance Officer
Details Of Agreements Entered Into With The Media Companies And Or Their Associates
Not Applicable
Details Of Business
Yes
Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy
Yes
Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30
Yes
Disclosure Of Related Party Transactions On Consolidated Basis
Yes
Disclosure Web Link Of Annual Return As Provided Under Section92Of The Companies Act2013Is Placed
https://www.valiantlabs.in/annual-return
Disclosure Web Link Of Company At Advertisements As Per Regulation471Is Placed
https://www.valiantlabs.in/newspaper-publications-for-financial-results
Disclosure Web Link Of Company At Dividend Distribution Policy As Per Regulation43A1Is Placed
https://www.valiantlabs.in/assets/images/investors/dividend_distribution_policy.pdf
Disclosure Web Link Of Company At Materiality Policy As Per Sub Regulation4Regulation30Is Placed
https://www.valiantlabs.in/assets/images/investors/policy_on_determination_of_materiality_of_event.pdf
Disclosure Web Link Of Company At Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity Is Placed
https://www.valiantlabs.in/audited-financial-statements-of-subsidiaries
Disclosure Web Link Of Company At Which Credit Rating Or Revision In Credit Rating Obtained Is Placed
https://www.valiantlabs.in/credit-ratings
Disclosure Web Link Of Company At Which Details Of Business Is Placed
https://www.valiantlabs.in/assets/images/investors/details_of_business.pdf
Disclosure Web Link Of Company At Which Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy Is Placed
https://www.valiantlabs.in/assets/images/investors/whistle_blower_policy.pdf
Disclosure Web Link Of Company At Which Financial Results Is Placed
https://www.valiantlabs.in/financial-information
Disclosure Web Link Of Company At Which Policy For Determining Material Subsidiaries Is Placed
https://www.valiantlabs.in/assets/images/investors/material_subsidiary.pdf
Disclosure Web Link Of Company At Which Policy On Dealing With Related Party Transactions Is Placed
https://www.valiantlabs.in/assets/images/investors/policy_on_dealing_with_related_party_transactions.pdf
Disclosure Web Link Of Company At Which Shareholding Pattern Is Placed
https://www.valiantlabs.in/shareholding-pattern
Disclosure Web Link Of Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation Is Placed
https://www.valiantlabs.in/shareholders-information-under-reg-46-of-sebi-lodr
Disclosure Web Link Of Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46Is Placed
https://www.valiantlabs.in/shareholders-information-under-reg-46-of-sebi-lodr
Disclosure Web Link Of Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30Is Placed
https://www.valiantlabs.in/corporate-governance
Disclosure Web Link Of Disclosures Under Sub Regulation8Of Regulation30Is Placed
https://www.valiantlabs.in/other-disclosures-on-stock-exchange-under-regulation-30-of-sebi-lodr
Disclosure Web Link Of Memorandum Of Association And Articles Of Association Is Placed
https://www.valiantlabs.in/assets/images/investors/moa-aoa_vll_final.pdf
Disclosure Web Link Of Secretarial Compliance Report Is Placed
https://www.valiantlabs.in/assets/images/investors/annual-secretarial-compliance-report-2024-2025.pdf
Disclosure Web Link Of Statements Of Deviations Or Variations As Specified In Regulation32Is Placed
https://www.valiantlabs.in/deviation-and-variations
Disclosures Under Sub Regulation8Of Regulation30
Yes
Dividend Distribution Policy As Per Regulation43A1
Yes
Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021
Not Applicable
Fees Or Compensation
Yes
Financial Results
Yes
Is SCORESID Available
Yes
ISIN
INE0JWS01017
Market Capitalisation As Per Immediate Previous Financial Year
Top 2000 listed entities
Materiality Policy As Per Sub Regulation4Regulation30
Yes
Memorandum Of Association And Articles Of Association
Yes
Minimum Information
Yes
MSEI Symbol
NOTLISTED
Name Of Signatory
Akshay Gangurde
Name Of Signatory Affirmations
Akshay Gangurde
Name Of Signatory For Annual Affirmations
Akshay Gangurde
Name Of Signatory For Quartely Affirmations
Akshay Gangurde
Name Of The Company
Valiant Laboratories Limited
New Name And The Old Name Of The Listed Entity
Not Applicable
Other Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity
Yes
Place
Mumbai
Plans For Orderly Succession For Appointments
Yes
Policy For Determining Material Subsidiaries
Yes
Policy For Related Party Transaction
Yes
Policy On Dealing With Related Party Transactions
Yes
Reason For Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Not Applicable To The Entity
Not applicable to the Company as no such Loans/Guarantees/Comfort Letters /Securities Etc are provided during the period
Recommendation Of Board
Yes
Reporting Quarter
Yearly
Review Of Compliance Reports
Yes
Risk Assessment And Management
Yes
Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet
Not Applicable
SCORES Registration ID
COMV00470
Scrip Code
543998
Secretarial Compliance Report
Yes
Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity
Yes
Shareholding Pattern
Yes
Statements Of Deviations Or Variations As Specified In Regulation32
Yes
Symbol
VALIANTLAB
The Listed Entity Has Approved Material Subsidiary Policy And The Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity Have Been Complied
Yes
Type Of Company
Equity
Type Of Submission
Original
Vacancies In Respect Key Managerial Personnel
Not Applicable
Vigil Mechanism
Yes
Whether As Per Sub Regulation2ba Of Regulation27Of SEBILODR There Has Been Cyber Security Incidents During The Quarter
No
Whether Part A Of Annexure I Of The SEBI Circular Dated31December2024Related To Compliance Report On Corporate Governance Is Applicable To The Entity
Yes
Whether Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Applicable To The Entity
No

Additional Disclosures

Entry D_MeetingBOD1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit4
Whether Requirement Of Quorum Met
Yes
Official NSE disclosure viewer

If the viewer does not load, use the NSE Viewer button above to open it in a new tab.

Board Composition — Entity Disclosures

The Composition Of Board Of Directors Is In Terms Of Sebi Regulations2015
Yes
Chairperson Related to MD / CEO
No
Regular Chairperson
Yes

Composition of Board of Directors

SrTitleDirectorPANDINCategory 1Category 2Category 3Date of BirthDisqualifiedStatusSpecial ResolutionInitial AppointmentRe-appointmentTenure (months)Listed DirectorshipsIndependent DirectorshipsAudit / Stakeholder MembershipsAudit / Stakeholder Chair Posts
1MrMulesh Manilal Savla******07474847Non-Executive - Independent DirectorChairperson12-Oct-1964NoActiveNot Applicable14-May-202414-May-202422.172243
2MrParesh Shashikant Shah******08291953Executive DirectorNot Applicable07-May-1960NoActiveNot Applicable16-Aug-202125-Sep-20251000
3MrSantosh Shantilal Vora******07633923Executive DirectorNot ApplicableMD25-Jul-1994NoActiveNot Applicable16-Aug-202106-Feb-20222010
4MrShantilal Shivji Vora******07633852Non-Executive - Non Independent DirectorNot Applicable05-Nov-1952NoActiveNot Applicable16-Aug-202106-Feb-20221010
5MrsSonal Amit Vira******09505883Non-Executive - Independent DirectorNot Applicable20-Oct-1982NoActiveNot Applicable16-Feb-202216-Feb-202249.152230
6MrSandeep Gupta******09245060Non-Executive - Non Independent DirectorNot Applicable08-Dec-1970NoActiveNot Applicable23-Feb-202323-Feb-20231000
7MrAshok Lakhamshi Chheda******10776571Non-Executive - Independent DirectorNot Applicable05-Jul-1975NoActiveNot Applicable12-Nov-202412-Nov-202416.191110

Committee Disclosures

Entry CompComit122
Date of Appointment
12-Aug-2024
Entry CompComit123
Date of Appointment
16-Feb-2022
Entry CompComit124
Date of Appointment
16-Feb-2022
Entry CompComit14
Date of Appointment
12-Aug-2024
Entry CompComit15
Date of Appointment
16-Feb-2022
Entry CompComit16
Date of Appointment
16-Feb-2022
Entry CompComit17
Date of Appointment
20-May-2025
Entry CompComit41
Date of Appointment
16-Feb-2022
Entry CompComit42
Date of Appointment
16-Feb-2022
Entry CompComit43
Date of Appointment
12-Aug-2024
Entry CompComit68
Date of Appointment
12-Aug-2024
Entry CompComit69
Date of Appointment
16-Feb-2022
Entry CompComit70
Date of Appointment
16-Feb-2022
Entry CompComit95
Date of Appointment
07-Feb-2025
Entry CompComit96
Date of Appointment
07-Feb-2025
Entry CompComit97
Date of Appointment
07-Feb-2025
Entry CompComit98
Date of Appointment
07-Feb-2025
Entry MainD
Composition And Role Of Risk Management Committee
Yes
Composition Of Audit Committee
Yes
Composition Of Nomination And Remuneration Committee
Yes
Composition Of Stakeholder Relationship Committee
Yes
Composition Of Various Committees Of Board Of Directors
Yes
Disclosure Web Link Of Company At Which Composition Of Various Committees Of Board Of Directors Is Placed
https://www.valiantlabs.in/composition-of-committees
Memberships In Committees
Yes
Prior Or Omnibus Approval Of Audit Committee For All Related Party Transactions
Yes
Risk Management Committee
No
Role Of Audit Committee And Information To Be Reviewed By The Audit Committee
Yes
Role Of Nomination And Remuneration Committee
Yes
Role Of Stakeholders Relationship Committee
Yes
The Committee Members Have Been Made Aware Of Their Powers Role And Responsibilities As Specified In Sebi Regulations2015
Yes
The Composition Of Audit Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Nomination And Remuneration Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Risk Management Committee Is In Terms Of Sebi Regulations2015
Not Applicable
The Composition Of The Stakeholders Relationship Committee Committee Is In Terms Of Sebi Regulations2015
Yes
Whether The Audit Committee Has A Regular Chairperson
Yes
Whether The Corporate Social Responsibility Committee Has A Regular Chairperson
Yes
Whether The Nomination And Remuneration Committee Has A Regular Chairperson
Yes
Whether The Risk Management Committee Has A Regular Chairperson
Yes
Whether The Stakeholders Relationship Committee Has A Regular Chairperson
Yes

Audit Committee

Additional Position
Chairperson
Director DIN
07474847
Member Name
Mulesh Manilal Savla
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
09505883
Member Name
Sonal Amit Vira
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
07633852
Member Name
Shantilal Shivji Vora
Position
Non-Executive - Non Independent Director

Audit Committee

Additional Position
Member
Director DIN
10776571
Member Name
Ashok Lakhamshi Chheda
Position
Non-Executive - Independent Director

Audit Committee

Audit Committee

Corporate Social Responsibility Committee

Additional Position
Chairperson
Director DIN
07474847
Member Name
Mulesh Manilal Savla
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
08291953
Member Name
Paresh Shashikant Shah
Position
Executive Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
07633852
Member Name
Shantilal Shivji Vora
Position
Non-Executive - Non Independent Director

Nomination and remuneration committee

Additional Position
Chairperson
Director DIN
09505883
Member Name
Sonal Amit Vira
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
07633852
Member Name
Shantilal Shivji Vora
Position
Non-Executive - Non Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
07474847
Member Name
Mulesh Manilal Savla
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Other Committee

Additional Position
Chairperson
Director DIN
07474847
Member Name
Mulesh Manilal Savla
Name Of Other Committee
Restructuring Committee
Position
Non-Executive - Independent Director

Other Committee

Additional Position
Member
Director DIN
10776571
Member Name
Ashok Lakhamshi Chheda
Name Of Other Committee
Restructuring Committee
Position
Non-Executive - Independent Director

Other Committee

Additional Position
Member
Director DIN
07633923
Member Name
Santosh Shantilal Vora
Name Of Other Committee
Restructuring Committee
Position
Executive Director

Risk Management Committee

Additional Position
Chairperson
Director DIN
07633923
Member Name
Santosh Shantilal Vora
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
09505883
Member Name
Sonal Amit Vira
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
07474847
Member Name
Mulesh Manilal Savla
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
08291953
Member Name
Paresh Shashikant Shah
Position
Executive Director

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
07474847
Member Name
Mulesh Manilal Savla
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
09505883
Member Name
Sonal Amit Vira
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
07633923
Member Name
Santosh Shantilal Vora
Position
Executive Director

Stakeholders Relationship Committee

Entry MainD
Gap Between The Meetings Of The Risk Management Committee
Yes
Meeting Of Audit Committee
Yes
Meeting Of Board Of Directors
Yes
Meeting Of Independent Directors
Yes
Meeting Of Nomination And Remuneration Committee
Yes
Meeting Of Risk Management Committee
Yes
Meeting Of Stakeholders Relationship Committee
Yes
Quorum Of Board Meeting
Yes
Quorum Of Nomination And Remuneration Committee Meeting
Yes
Quorum Of Risk Management Committeemeeting
Yes
The Meetings Of The Board Of Directors And The Above Committees Have Been Conducted In The Manner As Specified In Sebi Regulations2015
Yes
Entry MeetingBOD1
Dates Of Meeting In The Previous Quarter
11-Nov-2025
Number Of Directors Present In Meeting Of Board Of Directors
7
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
7
Entry MeetingBOD2
Dates Of Meeting If Any In The Relevant Quarter
11-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
91
Number Of Directors Present In Meeting Of Board Of Directors
7
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
7
Entry MeetingBOD3
Dates Of Meeting If Any In The Relevant Quarter
07-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
23
Number Of Directors Present In Meeting Of Board Of Directors
6
Number Of Independent Directors Attending The Meeting
2
Total Number Of Directors As On Date Of The Meeting
7
Entry MeetingComit1
Dates Of Meeting Of The Committee In The Previous Quarter
11-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit2
Dates Of Meeting Of The Committee In The Relevant Quarter
11-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
91
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit3
Dates Of Meeting Of The Committee In The Relevant Quarter
11-Feb-2026
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit4
Dates Of Meeting Of The Committee In The Relevant Quarter
11-Feb-2026
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MainD
Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances
Yes
Disclosure Web Link Of Company At Which Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances Is Placed
https://www.valiantlabs.in/shareholders-complaints-section
Disclosure Web Link Of Company At Which Email Address For Grievance Redressal And Other Relevant Details Is Placed
https://www.valiantlabs.in/shareholders-complaints-section
Email Address For Grievance Redressal And Other Relevant Details
Yes
No Of Investor Complaints Disposed Off During The Period
0
No Of Investor Complaints During The Period
0
No Of Investor Complaints Received During The Period
0
Whether Part B Of Annexure I Of The SEBI Circular Dated31December2024Related To Investor Grievance Redressal Report Is Applicable To The Entity
Yes
Entry MainI
No Of Investor Complaints
0
Entry PY_I
No Of Investor Complaints
0
Composition Of Board Of Directors Of Unlisted Material Subsidiary
Yes
Reason For Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Not Applicable To The Entity
As there were no acquisition of shares or voting rights in unlisted companies during the reporting quarter, Annexure I Part C is not applicable to the Company.
Whether Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Applicable To The Entity
No
Entry I_OngoingTaxLitigationsOrDisputes1
Current Status
The Show Cause Notice proposes a total GST demand aggregating to Rs.12,53,22,846/- (approximately Rs.12.53 Crore),along with applicable intrest and penalty under Section 50,74 and 122 of the CGST Act,2017. The Company shall file its detailed response to the Show-Cause Cum Demand Notice within the prescribed timeline.
Date of Initiation
14-Jan-2026
Opposing Party
Commissioner of CGST & Central Excise(Audit),Raigad,Vashi,Mumbai-400703
Status (Previous Disclosure)
On January 14,2026, the Company received a Show Cause Cum Demand Notice from the Office of Commissioner of CGST & Central Excise(Audit),Raigad,Vashi,Mumbai-400703 issued under the CGST Act 2017 and SGST Act 2017. The Violations alleged were: a. Ineligible ITC on IPO Expenses: Expenses incurred for the Initial Public Offer (IPO) are attributable to a “transaction in securities” (which is an exempt supply). The ITC was exclusively used for the supply of exempted goods. Consequently, the Input Tax Credit (ITC) claimed on these expenses (approx. Rs. 2.85 Cr) is considered ineligible. b. Turnover Mismatch (FY 2021-22): Short payment of GST due to a discrepancy between the taxable turnover declared in the Financial Statements and the GSTR-3B returns (approx. Rs. 9.31 Cr). This relates to the transition period of converting the partnership firm ‘Bharat Chemicals’ into ‘Valiant Laboratories Ltd’ c. Corporate Guarantee: Non-payment of GST on a Corporate Bank Guarantee of Rs. 100 Crore provided to a related party (M/s. Valiant Advanced Services Pvt Ltd). The department has valued this service at 2% per annum and demanded GST on it (approx. Rs. 36 Lakhs).
Entry I_OngoingTaxLitigationsOrDisputes2
Current Status
The Company on October 28, 2025, submitted the response to the Show Cause Notice recieved. The Company received an Order dated December 26, 2025 from the Office of the Assistant Commissioner of CGST & Central Excise, Division-IV, Navi Mumbai Commissionerate, CBD Belapur, Navi Mumbai. The order confirms a demand towards wrong availment of Input Tax Credit (ITC) on capital goods for FY 2021-22. The Company had claimed depreciation on the GST component of capital goods, which has been held to be impermissible. The authority has determined the ITC wrongly availed at Rs. 57,24,953/-. The Company on March 09, 2026, filed an appeal with the Appellate Authority.
Date of Initiation
29-Sep-2025
Opposing Party
Assistant Commissioner of CGST & Central Excise, Division-IV, Navi Mumbai Commissionerate, CBD Belapur, Navi Mumbai
Status (Previous Disclosure)
On September 29, 2025, the Company received a Show Cause Notice from the office of the Assistant Commissioner of CGST & Central Excise, Division-IV, Navi Mumbai Commissionerate, CBD Belapur, Navi Mumbai, issued under Section 73 of the CGST Act, 2017 read with relevant provisions of the IGST Act, 2017 and MGST Act, 2017, along with penalty under Section 122 of the CGST Act, 2017, relating to alleged wrong availment of Input Tax Credit on capital goods for the tax period April 2021 to March 2022. The Company is in the process of preparing and submitting its response to the Show-Cause Notice within the prescribed timeline.
Entry MainD
Whether Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Applicable To The Entity
Yes
Reason For Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Not Applicable To The Entity
During the quarter under review, there were no fine or penalty applicable to the entity which required disclosure under this report.
Whether Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Applicable To The Entity
No